Leucocyte migration inhibitory activity of concanavalin-A-stimulated lymphocytes. In vivo and in vitro modifications with dipyridamole and acetylsalicylic acid.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Acta Medica Scandinavica

• Publication date

  2009-04-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.0954-6820.1977.TB15681.XPMID 848356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lymphokines and thrombosis. Thrombocyte and coagulation activation by culture supernatants of concanavalin-A-stimulated human lymphocytes. Some physicochemical properties and inhibition by chemical compounds.

  2009cited by this paper
• Leucocyte migration inhibitory activity of concanavalin-A-stimulated human lymphocytes. Modification by dipyridamole, lysine-acetylsalicylate and heparin.

  2009cited by this paper
• LYMPHOKINES AND THROMBOSIS II. Procoagulant Activity Produced by Human Lymphocytes Stimulated with Concanavalin A (Con‐A)

  1976cited by this paper
• LYMPHOKINES AND THROMBOSIS

  1976cited by this paper
• AN IN VITRO ASSAY OF LEUKOCYTE MIGRATION INHIBITORY ACTIVITY FROM HUMAN LYMPHOCYTES STIMULATED WITH CONCANAVALIN A

  1975cited by this paper
• A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome.

  1975cited by this paper
• Role of the clotting system in cell-mediated hypersensitivity. II. Kinetics of fibrinogen/fibrin accumulation and vascular permeability changes in tuberculin and cutaneous basophil hypersensitivity reactions.

  1975cited by this paper
• Intervention of Dipyridamole and Acetylsalicylic Acid in the Deyelopment of Thrombosis in Cell-Mediated Immune Reactions: Possible Mechanism of Action

  1975cited by this paper
• Dipyridamole for proteinuria suppression. Use in a patient with proliferative glomerulonephritis.

  1974cited by this paper
• Treatment of thrombotic thrombocytopenic purpura with antiplatelet drugs.

  1973cited by this paper
• Coronary arteriography following cardiac transplantation.

  1972cited by this paper
• [Blood protein binding of the coronary dilator dipyridamol in man].

  1971cited by this paper
• Dipyridamole and Anticoagulants in Renal Disease due to Glomerular and Vascular Lesions A New Approach to Therapy

  1970cited by this paper

• Lymphokines and thrombosis. Thrombocyte and coagulation activation by culture supernatants of concanavalin-A-stimulated human lymphocytes. Some physicochemical properties and inhibition by chemical compounds.

  2009cites this paper
• Synergism between aspirin and cyclosporin-A

  2004cites this paper
• Pharmacology and Biochemistry of Salicylates and Related Drugs

  2004cites this paper
• Changes in bovine milk secretion following intramammary infusions of concanavalin A, oyster glycogen, or water.

  1986cites this paper
• Chapter 4 – Pharmacological and Biochemical Actions of the Salicylates

  1984cites this paper
• Production of human leukocyte migration inhibitory factor (LIF) by lymphocytes stimulated with phytohemagglutinin. I. Effect of various metabolic inhibitors.

  1981cites this paper
• Mediators of immunity: lymphokines and monokines.

  1980cites this paper
• [Anti-inflammatory action of acemetacin (author's transl)].

  1980cites this paper
• Actions of aspirin and dipyridamole on lymphocyte activation

  1980cites this paper
• Thrombocyte migration inhibitory activity of concanavalin-A-stimulated human lymphocytes. In vivo and in vitro modifications by dipyridamole and acetylsalicylic acid.

  1979cites this paper